News archive for Faculty of Medicine

The Western Norway Regional Health Authorities (Helse Vest) has recently announced their project funding for 2025, and we are happy to see many Neuro-SysMed researchers in their announcement. In addition, other funding agencies have also granted support to our projects this fall.

The result of years of collaboration between CCBIO PI Jim Lorens and Rolf Brekken and other colleagues in the USA, Finland, Romania and Norway, is now published in Science Signaling, with research identifying nuclear AKT3 as a new biomarker of advanced malignancy and revealing the pathway that activates AKT3 to drive epithelial-to-mesenchymal transition in pancreatic cancer.

This year, one of CCBIO's students got the opportunity to have a 3-month research stay in Boston, due to CCBIO's INTPART collaboration with Harvard Medical School and Boston Children's Hospital. PhD Candidate Tessa Lohr reports of a great experience, highly recommending it to other young researchers.

CNPase is an enzyme present at high levels in myelinating cells. Novel nanobody tools developed in an international collaboration were used to identify binding epitopes at atomic resolution and visualise myelin. Additionally, the nanobodies were used as intrabodies to bind to CNPase in living cells. These nanotools will be valuable for future research on myelin and its molecules.

The Department of Clinical Dentistry is proud of its participation in the 𝗡𝗼𝗿𝘄𝗲𝗴𝗶𝗮𝗻 𝗗𝗮𝘆 𝗜𝗧𝗔𝗣𝗔 – 𝗙𝗿𝗼𝗺 𝗥𝗲𝘀𝗲𝗮𝗿𝗰𝗵 𝘁𝗼 𝗖𝗵𝗮𝗻𝗴𝗲 at the Autumn ITAPA Conference 2024

This meeting at Solstrand August 28–31, 2024 was the 2nd Research Meeting in the INTPART collaboration between CCBIO and the Vascular Biology Program (VBP), Boston Children’s Hospital and Harvard Medical School, the first being the Iceland meeting in 2019. In 2019, 48 participants met in Iceland, and this year, 57 gathered at Solstrand.